Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
PeriPharm
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
1. ≥18 years old
2. Patients with PROC who received \>1 prior line of therapy identified through a screening survey. PROC will be defined as recurrence less than 6 months after last platinum chemotherapy (i.e. carboplatin or cisplatin)
3. Ability to read and understand French or English
4. Signature of ICF
1. ≥18 years old
2. Current caregiver of a patient with PROC (see definition to be used above) who received \>1 prior line of therapy identified through a screening survey.
3. Ability to read and understand French or English
4. Signature of ICF.
You may not be if
1. Patients with PSOC, defined as those who:
1. Have not progressed within less than 6 months after completion of platinum-based chemotherapy or;
2. Are still on platinum chemotherapy or;
3. Receive maintenance therapy.
2. Patients with platinum-refractory ovarian cancer, defined as not responding or disease progressing during therapy or within three months after the last dose
1. Caregivers of patients with PSOC (see definition above)
2. Caregivers of PROC patients who have passed away
3. Caregivers of platinum-refractory patients (see definition above)
Clareo Health | Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada
